XML 39 R32.htm IDEA: XBRL DOCUMENT v3.25.3
Stock Option and Grant Plan (Tables)
9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Summary of Stock-based Compensation Expense

Stock-based compensation expense recorded as research and development and general and administrative expenses in the condensed consolidated statements of operations and other comprehensive loss is as follows (in thousands):

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Research and development

 

$

13,840

 

 

$

18,371

 

 

$

44,405

 

 

$

54,819

 

General and administrative

 

 

8,907

 

 

 

11,188

 

 

 

29,391

 

 

 

35,625

 

Total stock-based compensation expense

 

$

22,747

 

 

$

29,559

 

 

$

73,796

 

 

$

90,444

 

Summary of Stock Option Activity Under Equity Award Plans

The following table provides a summary of stock option activity under the Company’s equity award plans:

 

 

Number
of options

 

 

Weighted
average
exercise
price

 

Outstanding at December 31, 2024

 

 

9,605,542

 

 

$

38.62

 

Granted

 

 

2,672,384

 

 

 

24.45

 

Exercised

 

 

(213,235

)

 

 

13.53

 

Forfeited

 

 

(516,463

)

 

 

43.43

 

Outstanding at September 30, 2025

 

 

11,548,228

 

 

 

35.60

 

Exercisable as of September 30, 2025

 

 

7,058,137

 

 

$

40.61

 

 

Summary of Restricted Stock Activity

The following table summarizes the Company’s restricted stock activity:

 

 

Shares

 

 

Weighted-
average grant
date fair
value

 

Unvested as of December 31, 2024

 

 

2,576,855

 

 

$

36.98

 

Issued

 

 

1,289,927

 

 

 

19.47

 

Vested

 

 

(783,939

)

 

 

46.31

 

Forfeited

 

 

(300,958

)

 

 

25.00

 

Unvested as of September 30, 2025

 

 

2,781,885

 

 

$

27.53